Cytokinetics: Q2 Earnings Snapshot
By AP News
Published - Aug 08, 2024, 05:01 PM ET
Last Updated - Aug 08, 2024, 05:01 PM EDT
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Thursday reported a loss of $143.3 million in its second quarter.
The South San Francisco, California-based company said it had a loss of $1.31 per share.
The results missed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $1.02 per share.
The biopharmaceutical company posted revenue of $249,000 in the period, also missing Street forecasts. Eight analysts surveyed by Zacks expected $13.5 million.
